SRPT · Healthcare · $1.9B
$18.22-2.25%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“매출이 1분기 7억3,100만 달러에서 2분기 4억100만 달러로 크게 되돌아왔고, 순제품 매출도 3억2,900만 달러에 그쳤어요.”
In the company's words · 2026 2분기 earnings call